Item

Clinical practice guideline for clozapine use in patients with COVID-19

Ansari, S
; 
Kelbrick, M
; 
Paduret, G
; 
Diaz, N
; 
Menzel, R
; 
Rogers, R
; 
Wareham, C
; 
Griffiths, C
; 
Jugon, S
; 
Tidy, K
... show 5 more
Abstract
National and local guidelines focus mainly on clozapine monitoring frequency, and actions based on full blood count results. Prescribing clozapine in the context of COVID-19-positive patients brings a complexity of challenge beyond this. In this article the authors put forward an example of a practical clinical guideline in this regard.
MIDER Authors
Citations
Altmetric:
Date
2023
Type
Article
Subject
Clozapine, Schizophrenia, COVID-19
Collections
NHFT Integrated Community Mental Health
Show all metadata
Citation
Ansari,S.;Kelbrick,M.;Paduret,G.;Diaz,N.;Menzel,R.;Rogers,R.;Wareham,C.;Griffiths,C.;Jugon,S.;Tidy,K.;Johnson,S.;Mann,N.;Tanner,J.;Millward,T.;Latif,S. (2023) Clinical practice guideline for clozapine use in patients with COVID-19. Progress in Neurology and Psychiatry 27(1) pp.31-36. https://doi.org/10.1002/pnp.779
Journal / Source Title
DOI
URI
https://mider.dspace7.openrepository.com/handle/20.500.12904/18976
PMID
Publisher
Publisher’s URL
Publisher’s statement
Note / Copyright